| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -1.39M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, KAPA returned -80.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -67.6% |
| 1 year | -80.5% |
| All-time high | $1.57 (Sep 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in KAPA would be worth today ›No. Kairos Pharma, Ltd. has not paid a dividend in the past 12 months.
Kairos Pharma, Ltd. stock trades on NYSEAMERICAN under the ticker symbol KAPA.
Kairos Pharma, Ltd. is part of the Healthcare sector.
Kairos Pharma, Ltd. has a market cap of 5.45M USD, based on the latest quote.